ƽÌØÎå²»ÖÐ

FcRn Inhibitors and Novel Options for Myasthenia Gravis

Tuesday, June 4, 2024 14:00to15:00

Muscular Dystrophy Canada (MDC) is pleased to present a webinar on the neonatal Fc receptor (FcRn) pathway for people with generalized Myasthenia Gravis (gMG)./infoneuroCategory: News

Back to top